Urology News

 

Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • EMA Panel Likes Breast and Kidney Cancer DrugsThe Committee for Medicinal Products for Human Use recommended approval of ribociclib for advanced HER+/HER2- breast cancer and tivozanib for advanced renal cell carcinoma.
  • ACOG Guidance: Individualize Breast Cancer ScreeningDecisions on when to start and end screening and on screening frequency should be made jointly by patients and providers, given the wide variation in major guidelines, ACOG said.
  • One Nut Allergy Doesn't Rule All Nuts OutContrary to past thinking, it isn't always necessary for someone with a nut allergy to dodge all nuts and seeds, and avoidance might even prompt more allergies, researchers warn.

Perspective

Business of Medicine

  • The War Over MOC Heats Up In at least 17 states, doctors are battling the American Board of Medical Specialties, hospitals, and insurers in an effort to make maintenance of certification optional. Here's how it's going.
  • A Hospital Gets Sued for Keeping a Patient Alive   Hospital clinicians who don't follow a patient's advance healthcare directive are at risk of being sued.

Columnists

Advisory Board

 

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape